Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    HLA-DQA1
Show Display Options
Rank Status Study
1 Not yet recruiting DC1s-CTL Cellular Therapy for Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Biological: DC1-CTL
2 Active, not recruiting A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
Condition: Breast Cancer
Interventions: Biological: HER-2 pulsed DC1;   Drug: trastuzumab;   Drug: pertuzumab
3 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Interventions: Biological: androgen ablation (AA);   Biological: DC1 vaccine
4 Completed HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
Conditions: Celiac Disease;   Gluten
Intervention: Dietary Supplement: Gluten challenge.
5 Temporarily not available Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Condition: Metastatic Cancer
Intervention: Biological: HER-2/neu Pulsed DC1 vaccine
6 Completed Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
Condition: Hepatitis B
Interventions: Biological: HBV-MPL vaccine 208129;   Biological: Engerix™-B
7 Completed Clinical Relevance of Typing HLA-DR7-DQ2
Conditions: Celiac Disease Patients Following Recommendations of ESPGHAN;   HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes
Intervention: Other: There is not any intervention
8 Recruiting DC Vaccine for Patients With Ductal Carcinoma In Situ
Conditions: Breast Cancer;   DCIS
Intervention: Biological: HER-2 Pulsed Dendritic cell Vaccine
9 Completed Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Conditions: Diarrhea;   Diarrhea Predominant Irritable Bowel Syndrome
Interventions: Other: Gluten free diet;   Other: Gluten rich diet
10 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
11 Completed Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
12 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
13 Recruiting Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Biological: Cisplatin + celecoxib + DC vaccine;   Biological: Cisplatin + CKM + Celecoxib + DC Vaccine
14 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
15 Completed Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
Conditions: Celiac Disease;   Non-celiac Gluten Sensitivity
Interventions: Dietary Supplement: Gluten challenge;   Dietary Supplement: Placebo challenge
16 Unknown  Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Condition: Malignant Glioma
Interventions: Biological: Dendritic vaccine pulsed with multiple peptides;   Biological: The first booster vaccine phase:;   Biological: The second booster vaccine phase:
17 Terminated
Has Results
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Device: Nautilus NeuroWaveTM System
18 Completed The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
19 Active, not recruiting HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy
Condition: Breast Cancer
Intervention: Biological: HER-2 pulsed Dendritic Cell Vaccine
20 Active, not recruiting HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
Condition: Breast Cancer
Intervention: Biological: HER-2 pulsed Dendritic Cell Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years